Hyperprolactinaemia, drug-induced

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat.

Hospital discharge: ATC codes for adverse effects of drugs ANY
Hospital Discharge: ICD-10 E22.1#

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector E4_HYPERPRO_ADVERSE

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5
Parent code in ICD-10 E22
Name in latin Hyperprolactinaemia

Summary Statistics

Key figures

All Female Male
Number of individuals 107 93 14
Unadjusted prevalence (%) 0.04 0.06 0.01
Mean age at first event (years) 40.05 37.86 54.60

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: E4_HYPERPRO_ADVERSE – Hyperprolactinaemia, drug-induced
GWS hits: 0

Survival analyses between endpoints

Plot

before Hyperprolactinaemia, drug-induced
after Hyperprolactinaemia, drug-induced

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hyperprolactinaemia, drug-induced